Fibromyalgia: From Clinical Invisibility to Medico-Legal Recognition
DOI:
https://doi.org/10.20344/amp.24611Keywords:
Cost of Illness, Disability Evaluation, Fibromyalgia, PortugalAbstract
n/a.
Downloads
References
Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Häuser W, Katz RL, et al. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016;46:319-29. DOI: https://doi.org/10.1016/j.semarthrit.2016.08.012
Branco JC, Rodrigues AM, Gouveia N, Eusébio M, Ramiro S, Machado PM, et al. Prevalence of rheumatic and musculoskeletal diseases and their impact on health-related quality of life, physical function and mental health in Portugal: results from EpiReumaPt. RMD Open. 2016;2:e000166. DOI: https://doi.org/10.1136/rmdopen-2015-000166
Häuser W, Henningsen P. Fibromyalgia syndrome: a somatoform disorder? Eur J Pain. 2014;18:1052-9. DOI: https://doi.org/10.1002/j.1532-2149.2014.00453.x
Direção-Geral da Saúde. Circular informativa n.º 27/DGCG de 17/09/2003. Lisboa: DGS; 2003.
Direção-Geral da Saúde. Circular informativa n.º 45/DGCG de 23/12/2005. Lisboa: DGS; 2005.
Direção-Geral da Saúde. Norma n.º 017/2016 de 27/12/2016, atualizada a 28/09/2017. Lisboa: DGS; 2017.
Portugal. Decreto-Lei n.º 352/2007. Diário da República, I Série, n.º 204 (2007/10/23).
Portugal. Portaria n.º 171/2025. Diário da República, I Série, n.º 71 (2025/04/10).
National Insurance Institute of Israel. Fibromyalgia Recognition Guidelines. Jerusalem: Bituach Leumi; 2021.
Diário Oficial da União, Brasil. Lei n.º 15.176, de 23 de Julho de 2025. Institui programa nacional de protecção aos direitos das pessoas acometidas por síndrome de fibromialgia. [consultado 2026 fev 18]. Disponível em: https://www2.camara.leg.br/legin/fed/lei/2025/lei-15176-23-julho-2025-797775-publicacaooriginal-175981-pl.html.
Arnold LM, Bennett RM, Crofford LJ, Dean LE, Clauw DJ, Goldenberg DL, et al. AAPT diagnostic criteria for fibromyalgia. J Pain. 2019;20:611-28. DOI: https://doi.org/10.1016/j.jpain.2018.10.008
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Acta Médica Portuguesa
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.
